Although human Th17 cells have no direct cytotoxic effect on cancer cells, Th17 cell-derived IL-17 and IFN-γ synergistically induce CXCL9 and CXC10 production in ovarian cancer, which in turn leads to recruitment of Th1-type effector T cells [31]. Here, CXCL9 is linked to ovarian carcinoma.